Government ContextGovernment Context
ActivityRulesGrantsPress releasesHearingsBills
ViewsAgenciesTopicsOrganizationsCommitteesLegislators
PricingLog inCreate account
Nonrulemaking

Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry; Availability

🏛 Food and Drug Administration (FDA)FDA-2026-D-1256
Pharmaceutical Policy
Documents
1
Total comments
154
all analyzed
Comment status
Open
Last activity
Apr 30, 2026
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

All 1Other 1
📄 Primary document
OtherFeb 25, 2026
Considerations for the use of the Plausible Mechanism Framework to Develop Individualized Therapies that Target Specific Genetic Conditions with Known Biological Cause; Draft Guidance for Industry
Closed on Apr 28, 2026💬 154 comments
Open →